This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Knoll Pharmaceutical Company, Abbott Gmbh & Co Kg, Basf Corporation. Active years: 2002-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2002-2010
Title: The Innovative Contributions of Jin-Wang Lai
Introduction
Jin-Wang Lai is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that combine ibuprofen with narcotic analgesics. With a total of 4 patents to his name, Lai's work has the potential to impact pain management therapies.
Latest Patents
Lai's latest patents focus on the formulation of pharmaceutical tablet compositions that include ibuprofen and narcotic analgesics. These compositions are designed to enhance the efficacy of pain relief medications. The patents detail methods for creating these compositions, which involve a series of steps including granulation, blending, and compression to form tablets. The specific ingredients outlined in his patents include colloidal silicon dioxide, various fillers, disintegrants, and binders, all aimed at optimizing the delivery of the active ingredients.
Career Highlights
Throughout his career, Jin-Wang Lai has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Knoll Pharmaceutical Company and BASF Corporation. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Lai has collaborated with several professionals in his field, including Gregory P. Kushla and Gerald P. Polli. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical compositions.
Conclusion
Jin-Wang Lai's contributions to the field of pharmaceuticals, particularly through his innovative patents, demonstrate his commitment to improving pain management therapies. His work continues to influence the development of effective medication formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile